Dominic Smethurst

CIK: 0001820549

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CRBP
Corbus Pharmaceuticals Holdings, Inc.
Mar 2, 2026
Sale(S)
Direct
6.1K shares at avg. $8.30$51K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Feb 3, 2026
Sale(S)
Direct
3.3K shares at avg. $8.09$27K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 14, 2026
Award(A)
Direct
28.4K shares-
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Mar 6, 2025
Sale(S)
Direct
6.4K shares at avg. $6.78$43K
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Jan 31, 2025
Award(A)
Direct
27.2K shares-

		Type	Shares	Price		Ownership
Mar 2, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	6,097	$8.30	$50,601	Direct
Feb 3, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	3,285	$8.09	$26,575	Direct
Jan 14, 2026	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	28,365	-	$0	Direct
Mar 6, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Sale(S)	6,393	$6.78	$43,330	Direct
Jan 31, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Award(A)	27,200	-	-	Direct

1-5 of 5 transactions

About Smethurst Dominic

Smethurst Dominic (SEC CIK 0001820549) files insider reports with the SEC as Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Signal8 holds 5 ownership filings by Smethurst Dominic, all Form 4s, filed between Feb 4, 2025 and Mar 4, 2026. Those filings report 5 transactions, from Jan 31, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Smethurst Dominic's filings is in NORWOOD, MA.

Recent filings by Smethurst Dominic

Mar 2, 2026: Open-market sale of CRBP shares (Form 4, code S).
Feb 3, 2026: Open-market sale of CRBP shares (Form 4, code S).
Jan 14, 2026: Grant or award of CRBP shares (Form 4, code A).
Mar 6, 2025: Open-market sale of CRBP shares (Form 4, code S).
Jan 31, 2025: Grant or award of CRBP shares (Form 4, code A).

Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Cormorant Asset Management, LP, Officer
Ben Yong, Director
Nicacio Leonardo Viana, Chief Medical Officer
Saxena Nishant C, Chief Business Officer
Cohen Yuval, Chief Executive Officer
Moran Sean F., Chief Financial Officer

How to read Form 4 transaction codes